Indication
Coagulation factor VIII
1 clinical trial
3 products
Clinical trial
POCUS: Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement TherapiesStatus: Recruiting, Estimated PCD: 2025-07-01
Product
EloctateProduct
AdynovateProduct
Emicizumab